Research summary, regulation or standard

EU-OSHA - BSS Directive Overview

Open the source page

In plain language

The EU Basic Safety Standards Directive limits occupational effective dose to 20 mSv a year and eye lens dose to 20 mSv a year. It requires worker classification, monitoring, medical surveillance and training, which apply to fluoroscopy teams in EU member states.

At a glance

Type of study
Regulation or standard
Who was studied
General population
Where
European Union
Summary based on
a web page

What it found

  • The occupational effective dose limit is 20 mSv per year, with up to 50 mSv in a single year allowed in special circumstances if the five-year average stays at or below 20 mSv.

    Key figures: 20 mSv in any single year; up to 50 mSv in special circumstances

  • The eye lens dose limit is 20 mSv per year or 100 mSv over any five consecutive years.

    Key figures: 20 mSv/year or 100 mSv in five consecutive years

  • Skin and extremity dose limit is 500 mSv per year; the limit for an unborn child is 1 mSv.

    Key figures: 500 mSv per year; 1 mSv

  • Exposed workers are classified as Category A, with individual monitoring based on category, at thresholds of 6 mSv effective dose, 15 mSv eye lens or 50 mSv skin and extremities.

    Key figures: 6 mSv effective; 15 mSv lens; 50 mSv skin/extremities

  • Employers are responsible for worker radiation protection, including informing workers of risks and the importance of early declaration of pregnancy, and must consult a radiation protection expert.

Limits to keep in mind

This is a secondary web summary of an EU directive, focused on occupational aspects, not a study. It gives no data on exposures or health outcomes, and national implementation may differ.

How this summary was made

ORSIF prepared this summary with AI assistance from a web page of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.